Genocea Biosciences Inc (GNCA) is higher by Tuesday morning, with the stock increasing 3.33% in pre-market trading to 1.24. GNCA's short-term technical score of 25 indicates that the stock has traded less bullishly over the last month than 75% of stocks on the market. In the Biotechnology industry, which ranks 136 out of 146 industries, the stock ranks higher than 47% of stocks. Genocea Biosciences Inc has risen 7.14% over the past month, closing at $1.17 on December 7. During this period of time, the stock fell as low as $0.95 and as high as $1.48. GNCA has an average analyst recommendation of Strong Buy. The company has an average price target of $6.38.
GNCA has an Overall Score of 35. Find out what this means to you and get the rest of the rankings on GNCA!